Literature DB >> 24757297

Comparison of Mass Versus Activity of Creatine Kinase MB and Its Utility in the Early Diagnosis of Re-infarction.

Simbita A Marwah1, Hitesh Shah1, Kiran Chauhan1, Amit Trivedi1, N Haridas1.   

Abstract

Currently employed markers for the detection of acute coronary syndrome are Troponin T, CK (Creatine Kinase) and CKMB activity. CKMB activity measured by immunoinhibition method can give falsely elevated results due to the presence of atypical CK and CKBB and at times lead to the mis-diagnosis of acute coronary syndrome. Hence, CKMB mass (CKMB) measured by electrochemiluminence sandwich principle was employed. In this cross-sectional study 183 samples of 61 patients were analyzed within 6 h of diagnosis of acute coronary syndrome and followed up to 72 h. The correlation coefficient between CKMB activity and CKMBM at 4-6 h was 0.744, while at 12-24 h it was 0.909 and at 48-72 h it was 0.337. Thus there was good association between the two methods at 12-24 h but, statistically for method comparison studies and for replacing one method by another, the two methods need to be in agreement with one another. In this study the two methods are not in agreement with one another and thus analytically not replaceable. Another finding was obtained that CKMBM reached cut off levels prior to CKMB enzyme activity and hence, CKMBM is clinically better than CKMB activity to detect reinfarction.

Entities:  

Keywords:  Acute coronary syndrome; CKMB enzyme activity; CKMB mass

Year:  2013        PMID: 24757297      PMCID: PMC3990811          DOI: 10.1007/s12291-013-0329-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

Review 1.  Applying the right statistics: analyses of measurement studies.

Authors:  J M Bland; D G Altman
Journal:  Ultrasound Obstet Gynecol       Date:  2003-07       Impact factor: 7.299

Review 2.  Biochemical markers of myocardial injury.

Authors:  M Kemp; J Donovan; H Higham; J Hooper
Journal:  Br J Anaesth       Date:  2004-04-19       Impact factor: 9.166

3.  Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB.

Authors:  J Mair; E Artner-Dworzak; A Dienstl; P Lechleitner; B Morass; J Smidt; I Wagner; C Wettach; B Puschendorf
Journal:  Am J Cardiol       Date:  1991-12-15       Impact factor: 2.778

4.  Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms: the second Emergency Medicine Cardiac Research Group Study.

Authors:  G P Young; W B Gibler; J R Hedges; J W Hoekstra; C Slovis; R Aghababian; M Smith; M Rubison; J Ellis
Journal:  Acad Emerg Med       Date:  1997-09       Impact factor: 3.451

5.  Effect of light and temperature on the stability of creatine kinase in human sera and controls.

Authors:  B Perry; B Doumas; B Jendrzejczak
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

6.  Further observations on the incidence and nature of atypical creatine kinase activity.

Authors:  S M Sax; J J Moore; J L Giegel; M Welsh
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Effect of macro-creatine kinase and increased creatine kinase BB on the rapid diagnosis of patients with suspected acute myocardial infarction in the emergency department.

Authors:  Muhittin A Serdar; Serhat Tokgoz; Gürkan Metinyurt; Serkan Tapan; Kürşat Erinç; Adnan Haşimi; Levent Kenar; Cumhur BilgI; Türker Kutluay
Journal:  Mil Med       Date:  2005-08       Impact factor: 1.437

9.  Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data.

Authors:  K N Lee; G Csako; P Bernhardt; R J Elin
Journal:  Clin Chem       Date:  1994-07       Impact factor: 8.327

10.  Concordance of creatine kinase-MB activity and mass.

Authors:  P R Eisenberg; D Shaw; C Schaab; A S Jaffe
Journal:  Clin Chem       Date:  1989-03       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.